453 related articles for article (PubMed ID: 35289983)
1. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
2. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA
BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the humoral and cellular response after the third COVID-19 vaccination in patients with autoimmune hepatitis.
Hartl J; Rüther DF; Duengelhoef PM; Brehm TT; Steinmann S; Weltzsch JP; Glaser F; Sterneck M; Sebode M; Weiler-Normann C; Lütgehetmann M; Schaub GM; Haag F; Schramm C; Wiesch JSZ; Lohse AW
Liver Int; 2023 Feb; 43(2):393-400. PubMed ID: 35840342
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
Taneja S; Mehtani R; De A; Mitra S; Rathi S; Verma N; Premkumar M; Minz R; Duseja A; Das A; Singh V; Dhiman RK; Chawla YK
J Clin Exp Hepatol; 2023; 13(2):241-251. PubMed ID: 36950480
[TBL] [Abstract][Full Text] [Related]
7. The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases.
Lee DU; Ponder R; Lee K; Menegas S; Fan GH; Chou H; Jung D; Lee K; Hastie DJ; Urrunaga NH
Hepatol Int; 2023 Jun; 17(3):720-734. PubMed ID: 36575337
[TBL] [Abstract][Full Text] [Related]
8. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
[TBL] [Abstract][Full Text] [Related]
9. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
Lamba M; Ngu JH; Stedman CAM
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):573-579.e1. PubMed ID: 32526342
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
11. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
[TBL] [Abstract][Full Text] [Related]
12. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta-analysis.
Jensen AH; Winther-Sørensen M; Burisch J; Bergquist A; Ytting H; Gluud LL; Wewer Albrechtsen NJ
Liver Int; 2023 Nov; 43(11):2479-2491. PubMed ID: 37752719
[TBL] [Abstract][Full Text] [Related]
14. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
16. Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases.
Goertz RS; GaBmann L; Strobel D; Wildner D; Schellhaas B; Neurath MF; Pfeifer L
Ann Hepatol; 2019; 18(1):23-29. PubMed ID: 31113596
[TBL] [Abstract][Full Text] [Related]
17. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
18. The role of complement activation in autoimmune liver disease.
Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
[TBL] [Abstract][Full Text] [Related]
19. Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases.
Silveira MG; Lindor KD
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):329-40. PubMed ID: 19072425
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune liver diseases and SARS-CoV-2.
Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
